Lv42
540 积分 2025-02-10 加入
Miastenia gravis. Actualización diagnóstica y terapéutica
6小时前
已完结
Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis (P1-5.006)
21小时前
已关闭
Long-term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Participants with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study
1天前
已关闭
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
1天前
已完结
皖公网安备34019202002308
